Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Oruka Therapeutics ROA 2010-2024 | ORKA

Current and historical return on assets (ROA) values for Oruka Therapeutics (ORKA) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
  
Oruka Therapeutics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-06-30 $-0.01B $0.03B -18.92%
2024-03-31 $-0.01B $0.04B -12.90%
2023-12-31 $-0.00B $0.04B -10.00%
2023-09-30 $-0.00B $0.04B -9.70%
2023-06-30 $-0.01B $0.04B -11.70%
2023-03-31 $-0.01B $0.04B -15.73%
2022-12-31 $-0.01B $0.04B -19.25%
2022-09-30 $-0.01B $0.05B -28.14%
2022-06-30 $-0.02B $0.05B -31.78%
2022-03-31 $-0.02B $0.05B -32.90%
2021-12-31 $-0.02B $0.06B -32.13%
2021-09-30 $-0.02B $0.06B -31.15%
2021-06-30 $-0.02B $0.07B -27.12%
2021-03-31 $-0.01B $0.07B -26.23%
2020-12-31 $-0.01B $0.05B -29.75%
2020-09-30 $-0.01B $0.05B -25.00%
2020-06-30 $-0.00B $0.01B -42.11%
2020-03-31 $-0.00B $0.01B -44.44%
2019-12-31 $-0.01B $0.01B -52.63%
2019-09-30 $-0.01B $0.01B -55.56%
2019-06-30 $-0.01B $0.01B -70.59%
2019-03-31 $-0.01B $0.01B -82.35%
2018-12-31 $-0.01B $0.01B -84.21%
2018-09-30 $-0.01B $0.01B -102.33%
2018-06-30 $-0.01B $0.01B -100.00%
2018-03-31 $-0.02B $0.01B -115.25%
2017-12-31 $-0.02B $0.01B -107.46%
2017-09-30 $-0.02B $0.02B -90.00%
2017-06-30 $-0.02B $0.02B -82.61%
2017-03-31 $-0.02B $0.02B -62.96%
2016-12-31 $-0.02B $0.03B -54.84%
2016-09-30 $-0.02B $0.03B -46.04%
2016-06-30 $-0.01B $0.03B -36.84%
2016-03-31 $-0.01B $0.04B -31.71%
2015-12-31 $-0.01B $0.04B -34.29%
2015-09-30 $-0.01B $0.04B -41.38%
2015-06-30 $-0.01B $0.05B -47.83%
2015-03-31 $-0.01B $0.01B -58.82%
2014-12-31 $-0.01B $0.02B -46.15%
2014-09-30 $-0.01B $0.02B -45.57%
2014-06-30 $-0.01B $0.02B -45.00%
2014-03-31 $-0.01B $0.02B -50.00%
2013-12-31 $-0.01B $0.02B -59.02%
2013-09-30 $-0.01B $0.02B -59.57%
2013-06-30 $-0.01B $0.02B -77.42%
2013-03-31 $-0.00B $0.00B -114.29%
2012-12-31 $-0.00B $0.00B -106.67%
2012-09-30 $-0.01B $0.00B -105.26%
2012-06-30 $-0.01B $0.00B -109.09%
2012-03-31 $-0.01B $0.01B -74.07%
2011-12-31 $-0.01B $0.01B -85.71%
2011-09-30 $-0.01B $0.01B -82.76%
2011-06-30 $-0.01B $0.01B -75.00%
2011-03-31 $-0.01B $0.01B -91.43%
2010-12-31 $-0.01B $0.01B -76.19%
2010-09-30 $-0.01B $0.01B -111.63%
2010-06-30 $-0.01B $0.01B -105.66%
2010-03-31 $-0.02B $0.01B -103.70%
2009-12-31 $-0.01B $0.01B -33.33%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.031B $0.000B
Oruka Therapeutics Inc. is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka Therapeutics Inc., formerly known as ARCA biopharma Inc., is based in WESTMINSTER, Colo.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $88.005B 35.06
Takeda Pharmaceutical (TAK) Japan $47.092B 9.43
Merck (MKGAF) Germany $24.640B 26.89
Astellas Pharma (ALPMY) Japan $21.861B 26.26
Summit Therapeutics (SMMT) United States $21.359B 0.00
Sandoz Group AG (SDZNY) Switzerland $17.662B 0.00
United Therapeutics (UTHR) United States $15.349B 15.85
Shionogi (SGIOY) Japan $13.202B 12.65
Neurocrine Biosciences (NBIX) United States $12.344B 36.93
Catalent (CTLT) United States $10.917B 0.00
Revolution Medicines (RVMD) United States $7.440B 0.00
Orion OYJ (ORINY) Finland $7.373B 30.02
Jazz Pharmaceuticals (JAZZ) Ireland $6.766B 7.18
Ionis Pharmaceuticals (IONS) United States $5.951B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.068B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.317B 0.00
Corcept Therapeutics (CORT) United States $4.020B 34.04
Dyne Therapeutics (DYN) United States $3.454B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.718B 15.68
PTC Therapeutics (PTCT) United States $2.598B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.542B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.426B 19.28
Soleno Therapeutics (SLNO) United States $2.052B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.869B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.865B 0.00
Xencor (XNCR) United States $1.649B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.636B 0.00
Harrow (HROW) United States $1.560B 0.00
Ardelyx (ARDX) United States $1.464B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.426B 0.00
Ocular Therapeutix (OCUL) United States $1.392B 0.00
Cassava Sciences (SAVA) United States $1.360B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.330B 0.00
Indivior (INDV) United States $1.315B 6.04
ARS Pharmaceuticals (SPRY) United States $1.255B 0.00
Evotec AG (EVO) Germany $1.240B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.221B 0.00
Collegium Pharmaceutical (COLL) United States $1.195B 6.86
Relay Therapeutics (RLAY) United States $1.086B 0.00
Enliven Therapeutics (ELVN) United States $1.057B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.020B 0.00
Bioventus (BVS) United States $0.896B 29.10
4D Molecular Therapeutics (FDMT) United States $0.856B 0.00
Cronos Group (CRON) Canada $0.856B 0.00
USANA Health Sciences (USNA) United States $0.730B 13.40
Ironwood Pharmaceuticals (IRWD) United States $0.714B 44.70
Savara (SVRA) United States $0.711B 0.00
ProKidney (PROK) United States $0.678B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.649B 0.00
Pacira BioSciences (PCRX) United States $0.622B 5.89
Exscientia (EXAI) United Kingdom $0.612B 0.00
Siga Technologies (SIGA) United States $0.570B 6.83
Eliem Therapeutics (ELYM) United States $0.553B 0.00
Silence Therapeutics (SLN) United Kingdom $0.546B 0.00
OmniAb (OABI) United States $0.539B 0.00
Altimmune (ALT) United States $0.539B 0.00
Tourmaline Bio (TRML) United States $0.516B 0.00
Foghorn Therapeutics (FHTX) United States $0.512B 0.00
KalVista Pharmaceuticals (KALV) United States $0.465B 0.00
Sage Therapeutics (SAGE) United States $0.462B 0.00
Verve Therapeutics (VERV) United States $0.459B 0.00
Aquestive Therapeutics (AQST) United States $0.452B 0.00
Xeris Biopharma Holdings (XERS) United States $0.429B 0.00
Larimar Therapeutics (LRMR) United States $0.427B 0.00
Elite Pharmaceuticals (ELTP) United States $0.416B 38.98
Zevra Therapeutics (ZVRA) United States $0.409B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.397B 0.00
Korro Bio (KRRO) United States $0.380B 0.00
Organogenesis (ORGO) United States $0.379B 0.00
Aldeyra Therapeutics (ALDX) United States $0.351B 0.00
Esperion Therapeutics (ESPR) United States $0.345B 0.00
Lyell Immunopharma (LYEL) United States $0.317B 0.00
Lexeo Therapeutics (LXEO) United States $0.317B 0.00
ESSA Pharma (EPIX) Canada $0.311B 0.00
Black Diamond Therapeutics (BDTX) United States $0.306B 0.00
Akebia Therapeutics (AKBA) United States $0.294B 0.00
Heron Therapeutics (HRTX) United States $0.278B 0.00
Avita Medical (RCEL) United States $0.267B 0.00
Nature's Sunshine Products (NATR) United States $0.256B 17.48
Acrivon Therapeutics (ACRV) United States $0.255B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.250B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.242B 0.00
Nektar Therapeutics (NKTR) United States $0.234B 0.00
Nanobiotix S.A (NBTX) France $0.232B 0.00
Pyxis Oncology (PYXS) United States $0.213B 0.00
MediWound (MDWD) Israel $0.195B 0.00
Profound Medical (PROF) Canada $0.190B 0.00
CytoDyn (CYDY) United States $0.189B 0.00
Innate Pharma SA (IPHYF) France $0.184B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.180B 0.00
Telomir Pharmaceuticals (TELO) United States $0.177B 0.00
Galectin Therapeutics (GALT) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.167B 0.00
Cardiol Therapeutics (CRDL) Canada $0.159B 0.00
Context Therapeutics (CNTX) United States $0.156B 0.00
Achieve Life Sciences (ACHV) Canada $0.152B 0.00
Prelude Therapeutics (PRLD) United States $0.143B 0.00
Century Therapeutics (IPSC) United States $0.135B 0.00
OptiNose (OPTN) United States $0.134B 0.00
Fractyl Health (GUTS) United States $0.127B 0.00
Assertio Holdings (ASRT) United States $0.118B 20.67
Journey Medical (DERM) United States $0.113B 0.00
Incannex Healthcare (IXHL) Australia $0.110B 0.00
CASI Pharmaceuticals (CASI) China $0.107B 0.00
Regulus Therapeutics (RGLS) United States $0.103B 0.00
Metagenomi (MGX) United States $0.103B 0.00
Karyopharm Therapeutics (KPTI) United States $0.095B 0.00
Relmada Therapeutics (RLMD) United States $0.091B 0.00
Citius Pharmaceuticals (CTXR) United States $0.091B 0.00
AlloVir (ALVR) United States $0.088B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.085B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.081B 0.00
PMV Pharmaceuticals (PMVP) United States $0.077B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.33
Arch Biopartners (ACHFF) Canada $0.071B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
Mural Oncology (MURA) Ireland $0.055B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Nutriband (NTRB) United States $0.050B 0.00
DURECT (DRRX) United States $0.048B 0.00
Inotiv (NOTV) United States $0.048B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.046B 0.00
ProPhase Labs (PRPH) United States $0.046B 0.00
FibroGen (FGEN) United States $0.045B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Protara Therapeutics (TARA) United States $0.039B 0.00
Gain Therapeutics (GANX) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Tempest Therapeutics (TPST) United States $0.034B 0.00
Enlivex Therapeutics (ENLV) Israel $0.033B 0.00
Surrozen (SRZN) United States $0.028B 0.00
VYNE Therapeutics (VYNE) United States $0.028B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.026B 0.00
Lipocine (LPCN) United States $0.025B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
Minerva Neurosciences (NERV) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.020B 0.78
TherapeuticsMD (TXMD) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
NRx Pharmaceuticals (NRXP) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Indaptus Therapeutics (INDP) United States $0.016B 0.00
Talphera (TLPH) United States $0.015B 0.00
Aptorum Group (APM) United Kingdom $0.015B 0.00
Nuvilex (PMCB) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Conduit Pharmaceuticals (CDT) United States $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
GlycoMimetics (GLYC) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Vivos Therapeutics (VVOS) United States $0.010B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Avalo Therapeutics (AVTX) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.52
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.69